Your session is about to expire
← Back to Search
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension
N/A
Recruiting
Research Sponsored by Jewish General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 hours
Awards & highlights
Study Summary
This trial will measure the improvement in lung function in patients with CTEPH before and after a balloon pulmonary angioplasty to open narrowed pulmonary arteries.
Who is the study for?
This trial is for patients with chronic thromboembolic pulmonary hypertension who are candidates for a procedure called balloon pulmonary angioplasty. People taking certain blood pressure medications or those with a heart condition known as patent foramen ovale cannot participate.Check my eligibility
What is being tested?
The study aims to measure the recovery of functional capillary surface area in the lungs of patients undergoing balloon pulmonary angioplasty, which is a treatment to widen narrowed arteries caused by chronic blood clots.See study design
What are the potential side effects?
Since this trial focuses on measuring lung function rather than testing a new drug or medical intervention, there are no direct side effects from the measurement process itself.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Increase in pulmonary functional capillary surface area
Trial Design
1Treatment groups
Experimental Treatment
Group I: Pre and post BPAExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Jewish General HospitalLead Sponsor
138 Previous Clinical Trials
272,354 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am taking medication for high blood pressure.I have a hole in my heart that didn't close after birth.I am eligible for a procedure to open lung blood vessels due to chronic blood clots.
Research Study Groups:
This trial has the following groups:- Group 1: Pre and post BPA
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger